OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
6758$29.0054

A-Spine Asia Co Ltd

Medical Equipment, Supplies & DistributionVerified

A-Spine Asia has a market capitalization of TWD 390.66 million, with a market price of TWD 29 per share. The company has 13.47 million shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for A-Spine Asia, as no financial performance data is provided in the valuation snapshot. Without access to industry_config preferred metrics or cohort medians, a direct comparison to industry peers is not possible at this time. The company's revenue concentration and geographic exposure are not disclosed in the available data. No segment or geographic breakdown is provided in the input, so it is not possible to assess the degree of diversification or concentration in any particular region or product line. Growth trajectory data is limited. No outlook numeric deltas or revenue history is provided in the input data, making it difficult to assess the company's growth potential or direction for the current or next fiscal year. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. The dilution risk is currently low, as no dilution is observed between basic and diluted shares. No adjustments have been applied to the valuation, and no dilution sources are identified in the input. Recent events, including filings or transcripts, are not disclosed in the available data. No specific events or disclosures are provided that would impact the company's operations or valuation.

30-day price · 6758-4.50 (-11.7%)
Low$34.00High$40.30Close$34.00As of15 May, 00:00 UTC
Profile
CompanyA-Spine Asia Co Ltd
Ticker6758.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. A-Spine Asia Co Ltd is a medical equipment and spine care solutions provider, offering products and services in the healthcare services and equipment sector.

Classification. A-Spine Asia is classified under the Healthcare economic sector, within the Healthcare Services & Equipment business sector, and the Medical Equipment, Supplies & Distribution industry, with a classification confidence of 0.92.

A-Spine Asia has a market capitalization of TWD 390.66 million, with a market price of TWD 29 per share. The company has 13.47 million shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for A-Spine Asia, as no financial performance data is provided in the valuation snapshot. Without access to industry_config preferred metrics or cohort medians, a direct comparison to industry peers is not possible at this time. The company's revenue concentration and geographic exposure are not disclosed in the available data. No segment or geographic breakdown is provided in the input, so it is not possible to assess the degree of diversification or concentration in any particular region or product line. Growth trajectory data is limited. No outlook numeric deltas or revenue history is provided in the input data, making it difficult to assess the company's growth potential or direction for the current or next fiscal year. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. The dilution risk is currently low, as no dilution is observed between basic and diluted shares. No adjustments have been applied to the valuation, and no dilution sources are identified in the input. Recent events, including filings or transcripts, are not disclosed in the available data. No specific events or disclosures are provided that would impact the company's operations or valuation.
Key takeaways
  • A-Spine Asia operates in the medical equipment and spine care solutions segment of the healthcare industry.
  • The company has a market capitalization of TWD 390.66 million, with no dilution observed between basic and diluted shares.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Profitability and return metrics are not available, limiting the ability to compare the company to industry peers.
  • No growth trajectory or revenue history is provided, making it difficult to assess future performance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$309.7M$20.9M$17.7M$3.6M
FY-3$330.2M$7.7M$8.0M$19.6M
FY-2$391.3M$9.4M$9.2M$7.8M
FY-1$404.9M$8.9M$8.4M$17.3M
FY0$448.8M$19.1M$15.1M$26.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$499.6M$289.2M$65.0M
FY-3$511.0M$277.1M$82.5M
FY-2$514.6M$274.0M$54.3M
FY-1$506.5M$270.8M$48.0M
FY0$519.5M$274.4M$56.6M
PeriodOCFCapExFCFSBC
FY-4$35.0M-$2.9M$3.6M
FY-3$18.3M-$4.6M$19.6M
FY-2$4.0M-$3.5M$7.8M
FY-1$17.5M-$4.5M$17.3M
FY0$29.7M-$1.6M$26.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price$29.00
Market cap$390.7M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
Metric6758Activity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity17.9% medp25 2.7% · p75 52.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 02:53 UTC#099aaab6
Market quoteclose TWD 37.50 · shares 0.01B diluted
no public URL
2026-05-02 02:53 UTC#f9d27621
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:10 UTCJob: 9f27bcfe